(Q51560081)

English

The role of sulphonylurea in combination therapy assessed in a trial of sulphonylurea withdrawal. Scandinavian Insulin-Sulphonylurea Study Group Research Team.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10547209

The role of sulphonylurea in combination therapy assessed in a trial of sulphonylurea withdrawal. Scandinavian Insulin-Sulphonylurea Study Group Research Team. (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10547209

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

6

object named as

Groop L

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

author name string

Landstedt-Hallin L

1

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10547209

Arner P

2

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10547209

Lins PE

3

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10547209

Bolinder J

4

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10547209

Olsen H

5

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10547209

publication date

1 October 1999

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10547209

Diabetic Medicine

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10547209

16

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10547209

10

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10547209

827-834

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10547209

Oral hypoglycemic agents

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Combination insulin/glyburide therapy in type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Insulin-glyburide combination therapy for non-insulin-dependent diabetes mellitus: a long-term double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Bedtime insulin/daytime glipizide. Effective therapy for sulfonylurea failures in NIDDM.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Comparison of Bedtime NPH or Preprandial Regular Insulin Combined With Glibenclamide in Secondary Sulfonylurea Failure

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Beginning insulin treatment of obese patients with evening 70/30 insulin plus glimepiride versus insulin alone. Glimepiride Combination Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Insulin plus a Sulfonylurea Agent for Treating Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Combined insulin-sulfonylurea therapy in treatment of NIDDM.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Effects of combined insulin-sulfonylurea therapy in type II patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

The significance and interpretation of mildly abnormal oral glucose tolerance

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

A Simple Method for the Determination of Serum Free Insulin Levels in Insulin-treated Patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Effect of a sulfonylurea and insulin on energy expenditure in type II diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Different effects of insulin and oral antidiabetic agents on glucose and energy metabolism in type 2 (non-insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Glyburide in non-insulin-dependent diabetes. Its therapeutic effect in patients with disease poorly controlled by insulin alone

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Efficacy of bedtime NPH insulin with daytime sulfonylurea for subpopulation of type II diabetic subjects.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00171.X

21 January 2018

Identifiers

10.1046/J.1464-5491.1999.00171.X

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10547209

release_tywqccaopbd4nok5xoumyklati

1 reference

https://api.fatcat.wiki/v0/release/tywqccaopbd4nok5xoumyklati

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10547209

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51560081&oldid=1842576851"